CRISPR-ko screen identifies RARα inhibition as a strategy to increase CD38 expression in multiple myeloma and potentiate anti-CD38 therapy.
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Laura Alibert, Sara scaramuzzino, Camille Soun, Guilhem Requirand, Nicolas Robert, Laure Vincent, Charles Herbaux, Guillaume Cartron, Caroline Bret, Sandrine Roulland, Jerome Moreaux, Sara Ovejero
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7108710993
Cites:
Cited by:
Related to: